Tenaya Therapeutics Inc.
TNYA | NASDAQ
$0.68
+$0.01 (+0.92%)
Sep 22, 2026, 1:01 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.34M | 225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | -2.19M | -101K | -1.86M | 2.08M | 2.08M | 2.12M | 4.28M | 7.27M | 10.24M | 11.09M | 11.82M | 11.69M | 11.51M | 10.3M | 8.71M | 6.97M | 5.23M | 4.46M | 3.85M | 2.74M | 1.69M | 689K |
Gross Profit | 3.52M | 326K | 1.86M | -2.08M | -2.08M | -2.12M | -4.28M | -7.27M | -10.24M | -11.09M | -11.82M | -11.69M | -11.51M | -10.3M | -8.71M | -6.97M | -5.23M | -4.46M | -3.85M | -2.74M | -1.69M | -689K |
Operating Income | -105.86M | -85.86M | -93.33M | -97.21M | -102.98M | -109.72M | -115.95M | -122.74M | -126.95M | -131.23M | -131.19M | -134.3M | -134.68M | -128.19M | -125.62M | -117.24M | -104.24M | -90.86M | -72.81M | -56.96M | -49.12M | -42.75M |
Interest Income | 2.72M | 2.84M | 2.68M | 2.92M | 3.34M | 3.92M | 4.74M | 5.4M | 6.09M | 6.54M | 7.06M | 6.62M | 5.44M | 3.83M | 1.95M | 984K | 411K | 198K | 108K | 46K | 30K | 39K |
Pretax Income | -103.12M | -83.01M | -90.6M | -94.26M | -99.62M | -105.77M | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M | -127.67M | -129.22M | -124.35M | -123.67M | -116.3M | -103.87M | -90.68M | -72.72M | -56.89M | -48.92M | -42.44M |
Net Income | -103.12M | -83.01M | -90.6M | -94.26M | -99.62M | -105.77M | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M | -127.67M | -129.22M | -124.35M | -123.67M | -116.3M | -103.87M | -90.68M | -72.72M | -56.89M | -48.92M | -42.44M |
Selling & General & Admin | 22.4M | 23.71M | 24.72M | 24.71M | 25.5M | 24.84M | 24.93M | 24.56M | 23.05M | 22.65M | 21.34M | 21.69M | 21.58M | 21.9M | 22.37M | 20.52M | 20.08M | 17.43M | 14.56M | 12.42M | 10.09M | 8.67M |
Research & Development | 61.61M | 62.37M | 68.61M | 72.5M | 77.48M | 82.76M | 86.74M | 90.92M | 93.66M | 97.49M | 98.04M | 100.92M | 101.59M | 95.99M | 94.54M | 89.74M | 78.93M | 68.96M | 54.39M | 41.8M | 37.34M | 33.39M |
Other Expenses | 25.37M | 101K | 1.86M | -2.08M | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 109.38M | 86.18M | 95.2M | 95.12M | 100.9M | 107.6M | 111.67M | 115.48M | 116.71M | 120.14M | 119.37M | 122.61M | 123.17M | 117.89M | 116.91M | 110.26M | 99.01M | 86.39M | 68.95M | 54.22M | 47.43M | 42.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 107.2M | 86.08M | 93.33M | 97.21M | 102.98M | 109.72M | 115.95M | 122.74M | 126.95M | 131.23M | 131.19M | 134.3M | 134.68M | 128.19M | 125.62M | 117.24M | 104.24M | 90.86M | 72.81M | 56.96M | 49.12M | 42.75M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 217.57M | 152.97M | 152.97M | 163.35M | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M | 27.2M |
Shares Outstanding (Diluted) | 217.57M | 152.97M | 152.97M | 163.35M | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M | 27.2M |
EPS (Basic) | -0.53 | -0.47 | -0.62 | -0.78 | -0.96 | -1.16 | -1.32 | -1.48 | -1.57 | -1.68 | -1.71 | -1.89 | -2.23 | -2.46 | -2.78 | -2.79 | -2.74 | -2.47 | -2.20 | -1.95 | -1.65 | -1.56 |
EPS (Diluted) | -0.53 | -0.47 | -0.62 | -0.78 | -0.96 | -1.16 | -1.32 | -1.48 | -1.57 | -1.68 | -1.71 | -1.89 | -2.23 | -2.46 | -2.78 | -2.79 | -2.74 | -2.47 | -2.20 | -1.95 | -1.65 | -1.56 |
EBITDA | -95.96M | -75.47M | -82.16M | -85.56M | -90.68M | -96.79M | -102.66M | -107.86M | -110.5M | -113.49M | -112.27M | -115.98M | -117.71M | -114.05M | -114.95M | -109.33M | -98.64M | -86.22M | -68.87M | -53.49M | -46.11M | -40.16M |
EBIT | -103.12M | -83.01M | -90.6M | -94.26M | -99.62M | -105.77M | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M | -127.67M | -129.22M | -124.35M | -123.67M | -116.3M | -103.87M | -90.68M | -72.72M | -56.89M | -49.08M | -42.74M |
Depreciation & Amortization | 7.15M | 7.54M | 8.44M | 8.7M | 8.94M | 8.97M | 8.47M | 9.37M | 10.24M | 11.09M | 11.82M | 11.69M | 11.51M | 10.3M | 8.71M | 6.97M | 5.23M | 4.46M | 3.85M | 3.4M | 2.98M | 2.59M |
Add to Watchlist
Select watchlists to add or remove TNYA